News

FDA has approved Protalix BioTherapeutics’ treatment protocol for prGCD, the proprietary plant-cell expressed recombinant form of glucocerebrosidase (GCD), for the treatment of Gaucher disease. The treatment protocol allows

BioSante Pharmaceuticals has presented H1N1 vaccine results at the Immunotherapeutics & Vaccine Summit in Providence, RI. BioSante claims that its vaccine adjuvant – BioVant has increased the protective

Par Pharmaceutical has announced that the US District Court for the District of Delaware has ruled in favor of Par in its challenge of Purdue’s patents relating to

Covidien has launched the NeoMode software upgrade for the Puritan Bennett 840 ventilator, an improvement designed to help clinicians better manage neonate patients. The NeoMode software upgrade enables

Tripos has released Benchware Pantheon, a software solution that enables discovery scientists to rapidly and accurately merge data from multiple sources, and then analyze and visualize it for

The FDA has approved Saphris tablets (asenapine) to treat adults with schizophrenia and bipolar I disorder. The efficacy of Saphris in treating schizophrenia was studied in three short-term

Biostar Pharmaceuticals has posted revenue of $13.2m for the second quarter of 2009, an increase of 40.6% compared to $9.4m for the second quarter of 2008. The company

FDA has approved Schering-Plough’s SAPHRIS (asenapine) sublingual tablets for acute treatment of schizophrenia and manic or mixed episodes, associated with bipolar I disorder with or without psychotic features,

GSK has issued an update on its progress to develop a vaccine against the Pandemic (H1N1) 2009 influenza virus. The company has also commenced the clinical development program